140 related articles for article (PubMed ID: 20302534)
21. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Abdul-Hussein M; Freeman J; Castell D
Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
[TBL] [Abstract][Full Text] [Related]
22. Systematic review: Rebound acid hypersecretion after therapy with proton pump inhibitors.
Hunfeld NG; Geus WP; Kuipers EJ
Aliment Pharmacol Ther; 2007 Jan; 25(1):39-46. PubMed ID: 17229219
[TBL] [Abstract][Full Text] [Related]
23. Is acid relevant in the genesis of dyspeptic symptoms associated with nonerosive reflux disease?
Savarino V; Savarino E
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):252-4. PubMed ID: 18334866
[TBL] [Abstract][Full Text] [Related]
24. Review article: the pharmacological inhibition of gastric acid secretion--tolerance and rebound.
Sandvik AK; Brenna E; Waldum HL
Aliment Pharmacol Ther; 1997 Dec; 11(6):1013-8. PubMed ID: 9663823
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitors for dyspepsia.
Vakil N
Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
[TBL] [Abstract][Full Text] [Related]
26. [Update on current care guidelines. A current care guideline: recurrent upper gastrointestinal symptoms].
Paikka N
Duodecim; 2012; 128(22):2376-7. PubMed ID: 23342484
[TBL] [Abstract][Full Text] [Related]
27. Dyspepsia and reflux in primary care: rough DIAMOND of a trial.
van Zanten SV
Lancet; 2009 Jan; 373(9659):187-8. PubMed ID: 19150689
[No Abstract] [Full Text] [Related]
28. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
Tack J; Louis E; Persy V; Urbain D
Acta Gastroenterol Belg; 2013 Dec; 76(4):393-402. PubMed ID: 24592542
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and pharmacodynamics of acid-suppressive agents in patients with gastroesophageal reflux disease.
Schentag JJ; Goss TF
Am J Hosp Pharm; 1993 Apr; 50(4 Suppl 1):S7-10. PubMed ID: 8097364
[TBL] [Abstract][Full Text] [Related]
30. Targeting gastrin for the treatment of gastric acid related disorders and pancreatic cancer.
Morton M; Prendergast C; Barrett TD
Trends Pharmacol Sci; 2011 Apr; 32(4):201-5. PubMed ID: 21397342
[TBL] [Abstract][Full Text] [Related]
31. Medical therapy for gastroesophageal reflux disease in 2007.
Katz PO
Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
[TBL] [Abstract][Full Text] [Related]
32. [25 years of gastric acid blockers].
Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2501-4. PubMed ID: 10627749
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
Huang JQ; Hunt RH
Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
[TBL] [Abstract][Full Text] [Related]
34. Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment.
Lødrup AB; Reimer C; Bytzer P
Scand J Gastroenterol; 2013 May; 48(5):515-22. PubMed ID: 23311977
[TBL] [Abstract][Full Text] [Related]
35. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
36. Acid inhibition and the acid rebound effect.
Lerotić I; Baršić N; Stojsavljević S; Duvnjak M
Dig Dis; 2011; 29(5):482-6. PubMed ID: 22095014
[TBL] [Abstract][Full Text] [Related]
37. [H2-blockers in the pediatric practice: is the potential exhausted?].
Bel'mer SV; Kovalenko AA; Gasilina TV
Eksp Klin Gastroenterol; 2005; (6):19-22. PubMed ID: 17378381
[No Abstract] [Full Text] [Related]
38. [Antisecretory potential of pantoprasole (sanpraz)].
Kurilovich SA; Chernosheĭkina LE
Eksp Klin Gastroenterol; 2008; (7):119-22. PubMed ID: 19334455
[No Abstract] [Full Text] [Related]
39. Correlation between oesophageal acid exposure and dyspeptic symptoms in patients with nonerosive reflux disease.
Sarnelli G; De Giorgi F; Efficie E; Aprea G; Masone S; Savarese MF; Esposito I; Russo L; Cuomo R
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):264-8. PubMed ID: 18334868
[TBL] [Abstract][Full Text] [Related]
40. [Barrett esophagus: modern diagnosis, drug therapy and reduce risk of cancer].
Kashin SV; Ivanikov IO
Eksp Klin Gastroenterol; 2009; (2):90-8. PubMed ID: 19552026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
